Page last updated: 2024-08-24

imiquimod and Disbacteriosis

imiquimod has been researched along with Disbacteriosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Daien, CI; King, NJC; Macia, L; Mielle, J; Moore, RJ; Ni, D; Pinget, GV; Simpson, S; Stanley, D; Taitz, J; Tan, JK1
Dandekar, S; Garcia-Melchor, E; Haas, KN; Huynh, M; Hwang, ST; Law, T; Millar, NL; Nguyen, M; Rolston, M; Santos Rocha, C; Shi, Z; Wan, YY; Wu, X; Yamada, D1

Other Studies

2 other study(ies) available for imiquimod and Disbacteriosis

ArticleYear
Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development.
    Cell reports, 2022, 08-16, Volume: 40, Issue:7

    Topics: Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Imiquimod; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Psoriasis

2022
Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice.
    The Journal of investigative dermatology, 2021, Volume: 141, Issue:7

    Topics: Animals; Arthritis, Psoriatic; Diet, Western; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Humans; Imiquimod; Interleukin-23; Mice; Psoriasis; Signal Transduction

2021